Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
PRILOZI
Volume 39 (2018): Issue 2-3 (December 2018)
Open Access
Epidemiological Analysis and Geographical Distribution of Patients Suffering from Rheumatoid Arthritis, Eligible for First-Line Therapy/Monotherapy Treatment with Subcutaneous Formulation of Tocilizumab in the Republic of Macedonia
Filip Gucev
Filip Gucev
,
Snezana Perchinkova-Mishevska
Snezana Perchinkova-Mishevska
,
Georgi Bozinovski
Georgi Bozinovski
,
Irena Kafedjiska
Irena Kafedjiska
,
Dubravka Antova
Dubravka Antova
,
Ljubinka Damjanovska-Krstic
Ljubinka Damjanovska-Krstic
,
Bashkim Osmani
Bashkim Osmani
,
Fjola Hadjihamza
Fjola Hadjihamza
and
Oliver Nikolov
Oliver Nikolov
| Dec 31, 2018
PRILOZI
Volume 39 (2018): Issue 2-3 (December 2018)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Dec 31, 2018
Page range:
69 - 78
DOI:
https://doi.org/10.2478/prilozi-2018-0044
Keywords
Rheumatoid arthritis
,
tocilizumab
,
first-line treatment/monotherapy
,
subcutaneous
© 2018 Filip Gucev et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Filip Gucev
University Clinic of Rheumatology,
Skopje
Snezana Perchinkova-Mishevska
University Clinic of Rheumatology,
Skopje
Georgi Bozinovski
University Clinic of Rheumatology,
Skopje
Irena Kafedjiska
University Clinic of Rheumatology,
Skopje
Dubravka Antova
University Clinic of Rheumatology,
Skopje
Ljubinka Damjanovska-Krstic
University Clinic of Rheumatology,
Skopje
Bashkim Osmani
University Clinic of Rheumatology,
Skopje
Fjola Hadjihamza
Skopje
Oliver Nikolov
Skopje